|
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
| 219.16 USD | +0.13% |
|
-9.72% | -2.47% |
| 01-13 | Veeva Systems Inc. Presents at 44th Annual J.P. Morgan Healthcare Conference, Jan-13-2026 01:30 PM | |
| 01-08 | Veeva Systems, BioMarin Pharmaceutical Enter Long-Term Partnership | MT |
| Capitalization | 35.98B 30.87B 28.74B 26.75B 49.92B 3,248B 53.81B 330B 130B 1,554B 135B 132B 5,693B | P/E ratio 2026 * |
41.4x | P/E ratio 2027 * | 37x |
|---|---|---|---|---|---|
| Enterprise value | 29.33B 25.17B 23.43B 21.81B 40.69B 2,648B 43.87B 269B 106B 1,267B 110B 108B 4,641B | EV / Sales 2026 * |
9.23x | EV / Sales 2027 * | 7.78x |
| Free-Float |
90.83% | Yield 2026 * |
-
| Yield 2027 * | - |
Last Transcript: Veeva Systems Inc.
| 1 day | +0.13% | ||
| 1 week | -9.72% | ||
| Current month | -2.47% | ||
| 1 month | -1.09% | ||
| 3 months | -24.24% | ||
| 6 months | -22.06% | ||
| Current year | -2.47% |
| 1 week | 216.43 |  | 245.49 |
| 1 month | 215.3 | | 245.49 |
| Current year | 216.43 | | 245.49 |
| 1 year | 201.54 | | 310.5 |
| 3 years | 157.3 | | 310.5 |
| 5 years | 151.02 | | 343.96 |
| 10 years | 19.97 | | 343.96 |
| Manager | Title | Age | Since |
|---|---|---|---|
Peter Gassner
CEO | Chief Executive Officer | 61 | 2007-01-11 |
Tom Schwenger
PSD | President | 58 | 2019-09-29 |
Eleni Zuppas
PSD | President | 56 | 2024-03-31 |
| Director | Title | Age | Since |
|---|---|---|---|
Peter Gassner
BRD | Director/Board Member | 61 | 2011-08-03 |
Matthew Wallach
BRD | Director/Board Member | 53 | 2019-12-31 |
Gordon Ritter
CHM | Chairman | 61 | 2008-07-31 |
| Name | Varia. Jan 1. | Weight | AuM | |
|---|---|---|---|---|
 | -.--% | 2.37% | 1 M€ | |
| -1.59% | 2.36% | 5 M€ | |
| +1.05% | 2.34% | 51 M€ |
| Change | 5d. change | 1-year change | 3-years change | Capi.($) | ||
|---|---|---|---|---|---|---|
| +0.13% | -9.72% | +2.82% | +33.05% | 35.98B | |
| -2.83% | -4.00% | -18.74% | +250.05% | 14.84B | |
| +1.33% | +0.17% | -6.81% | +48.99% | 4.88B | |
| -4.83% | +36.17% | - | - | 4.13B | |
| +0.39% | +4.84% | - | - | 2.98B | |
| +3.85% | +22.86% | - | - | 2.61B | |
| -0.35% | -0.80% | +16.36% | -12.86% | 2.28B | |
| -6.18% | +21.53% | +15.84% | - | 1.66B | |
| -6.33% | +21.05% | +43.42% | -24.54% | 1.47B | |
| -3.92% | +16.14% | +53.24% | -4.06% | 934M | |
| Average | -1.87% | +12.02% | +15.16% | +48.44% | 7.17B | |
| Weighted average by Cap. | -0.89% | -0.01% | -0.53% | +83.96% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 3.18B 2.73B 2.54B 2.36B 4.41B 287B 4.75B 29.19B 11.48B 137B 11.92B 11.67B 503B | 3.56B 3.05B 2.84B 2.64B 4.93B 321B 5.32B 32.66B 12.85B 154B 13.33B 13.06B 563B |
| Net income | 895M 768M 715M 665M 1.24B 80.79B 1.34B 8.22B 3.23B 38.65B 3.36B 3.29B 142B | 1.02B 875M 815M 758M 1.42B 92.08B 1.53B 9.37B 3.69B 44.05B 3.83B 3.75B 161B |
| Net Debt | -6.65B -5.7B -5.31B -4.94B -9.22B -600B -9.94B -61.06B -24.02B -287B -24.93B -24.41B -1,052B | -8.32B -7.14B -6.65B -6.19B -11.55B -751B -12.45B -76.44B -30.07B -359B -31.21B -30.56B -1,317B |
| Date | Price | Change | Volume |
|---|---|---|---|
| 26-01-15 | 217.86 $ | -0.45% | 222,946 |
| 26-01-14 | 218.86 $ | -4.21% | 2,177,559 |
| 26-01-13 | 228.49 $ | -2.02% | 1,448,275 |
| 26-01-12 | 233.21 $ | -2.88% | 1,516,405 |
| 26-01-09 | 240.12 $ | -0.43% | 1,589,772 |
Delayed Quote Nyse, January 15, 2026 at 09:51 am
More quotes
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Global Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Global Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite), and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be performed. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of the rankings based on the following ratings: Capital Efficiency (Composite), Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully review the associated descriptions.
Quarterly revenue - Rate of surprise
- Stock Market
- Equities
- VEEV Stock
Select your edition
All financial news and data tailored to specific country editions
MarketScreener is also available in this country: United States.
Switch edition